(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var | |
| Sales | 41.32 | 32.10 | 28.72 | 104.34 | 106.91 | -2.40 | 151.88 | 120.72 | 25.81 |
| Other Income | 0.67 | 0.06 | 1016.67 | 1.75 | 1.76 | -0.57 | 2.80 | 2.01 | 39.30 |
| PBIDT | 3.64 | 2.33 | 56.22 | 8.86 | 7.89 | 12.29 | 11.88 | 9.62 | 23.49 |
| Interest | 0.18 | 0.41 | -56.10 | 0.29 | 0.74 | -60.81 | 0.90 | 0.54 | 66.67 |
| PBDT | 3.46 | 1.92 | 80.21 | 8.57 | 7.15 | 19.86 | 10.98 | 9.08 | 20.93 |
| Depreciation | 0.28 | 0.33 | -15.15 | 0.84 | 0.99 | -15.15 | 1.12 | 1.29 | -13.18 |
| PBT | 3.18 | 1.59 | 100.00 | 7.73 | 6.16 | 25.49 | 9.86 | 7.79 | 26.57 |
| TAX | 0.80 | 0.41 | 95.12 | 1.93 | 1.51 | 27.81 | 2.39 | 2.02 | 18.32 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.08 | -87.50 |
| PAT | 2.38 | 1.18 | 101.69 | 5.80 | 4.65 | 24.73 | 7.47 | 5.77 | 29.46 |
| Equity | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 |
| PBIDTM(%) | 8.81 | 7.26 | 21.36 | 8.49 | 7.38 | 15.06 | 7.82 | 7.97 | -1.84 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.00 |
| Dr. Reddys Lab | 1224.00 |
| Cipla | 1231.40 |
| Zydus Lifesciences | 931.00 |
| Lupin | 2326.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: